Is Jisandai (Epclusa) effective after taking it for one month and suggestions for observation of the course of treatment?

Epclusa (Epclusa) is an oral anti-hepatitis C virus (HCV) direct antiviral drug (DAA), used to treat patients with chronic hepatitis C of various genotypes. Its main ingredients are a combination of sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir), which can effectively inhibit virus replication and achieve virological cure. In clinical practice, Jisandai is widely used due to its short treatment course, high cure rate and good tolerance.

Usually, the standard treatment course of Jisanda is 12 weeks (about 3 months). After one month of taking it, the serum HCV RNA levels of most patients will drop significantly, and some patients may not even be able to detect the virus, but this does not mean they have been completely cured. Complete clearance of the virus can only be determined by completing the entire course of treatment and retesting virological indicators (SVR12) about 12 weeks after stopping the drug. Therefore, the one-month course of treatment can only be used as a preliminary observation of the efficacy, and the treatment cannot be stopped in advance.

During the period of taking the medicine, patients should take it on time every day and not miss a dose or stop the medicine on their own to ensure that the blood concentration of the medicine is maintained at an effective level. Missing doses may lead to viral rebound or increase the risk of drug resistance. In addition, patients should regularly review liver function, blood routine and virological indicators so that doctors can evaluate the treatment effect and make individual adjustments as needed.

In short, the efficacy of Jisandai can be initially observed within one month, but the full course of treatment must be completed to obtain reliable curative effects. During the treatment period, patients should adhere to standardized medication, regular reexamination, and cooperate with a healthy lifestyle, such as abstaining from alcohol, eating a reasonable diet, and exercising moderately, to improve the efficacy and reduce the risk of recurrence.

Reference materials:https://www.drugs.com/